id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-324660-w81jgw7p	Guharoy, Roy	Medication Shortages: A Matter of National Security—Time for Action	2020-08-01		.txt	text/plain	1105	56	47	To the Editor: As noted by Choo and Rajkumar 1 in the June 2020 issue of Mayo Clinic Proceedings, the COVID-19 (coronavirus disease 19) pandemic has exposed extreme vulnerabilities in our nation's drug supply chain. d Create a national database for tracking of essential drug supplies and use predictive analytics to identify surge, production problems, and future shortages. 1 As supply chain management leaders at Mayo Clinic, we appreciate the attention these authors draw towards the issue of drug shortages and drug costs. 5 Because of the high use of vasopressin in critically ill COVID-19 patients and the greater than 6000% price increase that has occurred after completing the Unapproved Drugs Initiative process, vasopressin will likely become a top 10 drug expense within the hospital sector by the end of 2020. The FDA Unapproved Drugs Initiative: an observational study of the consequences for drug prices and shortages in the United States	./cache/cord-324660-w81jgw7p.txt	./txt/cord-324660-w81jgw7p.txt